Close Menu

NEW YORK — Quest Diagnostics, through its Cleveland HeartLab subsidiary, has entered into an agreement to purchase for $8.5 million certain assets of bankrupt testing firm True Health Diagnostics.

A Quest spokesperson said in an email that it will not be acquiring any of True Health's facilities or staff and that it expected the acquisition to expand the reach of its cardio-metabolic diagnostic services to new groups of patients and providers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.